詳細検索

詳細検索

お問い合わせ

Diabetes Monitoring Devices Market Insights, Competitive Landscape, and Market Forecast - 2033

Diabetes Monitoring Devices Market Insights, Competitive Landscape, and Market Forecast - 2033


The Diabetes Monitoring Devices Market is steadily advancing as healthcare systems worldwide respond to the growing burden of diabetes with improved diagnostic and monitoring solutions. The market ... もっと見る

 

 

出版社
Fairfield Market Research
フェアフィールドマーケットリサーチ
出版年月
2026年4月23日
電子版価格
US$4,995
シングルユーザライセンス
ライセンス・価格情報/注文方法はこちら
納期
通常5営業日以内
ページ数
192
言語
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

Summary

The Diabetes Monitoring Devices Market is steadily advancing as healthcare systems worldwide respond to the growing burden of diabetes with improved diagnostic and monitoring solutions. The market is projected to expand from 12.4 bn in 2026 to 19.1 bn by 2033, registering a CAGR of 6.30% over the forecast period. This upward trajectory is supported by increasing awareness of diabetes management, a surge in demand for real-time monitoring technologies, and the rapid integration of digital health tools into routine care. As patients and providers shift toward proactive disease management, the role of advanced monitoring devices continues to strengthen across both clinical and homecare environments.

Market Insights

The market is undergoing a notable transformation driven by technological innovation and evolving patient needs. Continuous glucose monitoring devices are gaining widespread acceptance due to their ability to provide real-time insights and reduce dependence on traditional finger-prick testing methods. At the same time, insulin delivery devices are becoming more sophisticated, offering features such as automated dosing, connectivity with mobile applications, and improved usability. The integration of cloud computing and data analytics is enabling better tracking of patient health metrics, supporting personalized treatment approaches. Additionally, the growing preference for home-based healthcare solutions is encouraging the development of compact, easy-to-use, and connected monitoring systems.

Drivers

The increasing global prevalence of diabetes remains a key factor driving market growth. Lifestyle changes, rising obesity levels, and an aging population are contributing to a higher incidence of both type 1 and type 2 diabetes. Technological advancements are also playing a crucial role, with innovations in sensor technology, wearable devices, and mobile health platforms enhancing monitoring accuracy and patient compliance. Government initiatives aimed at improving diabetes care and promoting early diagnosis are further supporting market expansion. Moreover, the rising awareness among patients about the importance of continuous monitoring is encouraging the adoption of advanced devices that offer convenience and better health outcomes.

Business Opportunity

The Diabetes Monitoring Devices Market offers significant growth opportunities for companies focusing on innovation and accessibility. The increasing demand for non-invasive and wearable monitoring solutions provides a strong platform for product differentiation. Emerging economies present substantial potential due to expanding healthcare infrastructure and rising disposable incomes. Companies that invest in digital health integration, including telemedicine and remote patient monitoring, are likely to gain a competitive advantage. Strategic collaborations and partnerships can further enhance product portfolios and market reach. Additionally, the development of affordable devices tailored to underserved populations can unlock new growth avenues and strengthen market penetration.

Region Analysis

North America continues to lead the Diabetes Monitoring Devices Market, supported by a high prevalence of diabetes, advanced healthcare systems, and strong adoption of innovative technologies. Favorable reimbursement policies and the presence of major industry players further reinforce regional dominance. Europe follows with steady growth driven by increasing healthcare awareness and government support for chronic disease management. The Asia Pacific region is expected to experience the fastest growth, fueled by a rapidly increasing diabetic population, improving healthcare access, and rising adoption of digital health technologies. Countries such as India and China are emerging as key contributors due to their large patient base and ongoing healthcare developments. Latin America and the Middle East and Africa are also showing gradual progress, supported by improving healthcare infrastructure and growing awareness initiatives.

Key Players

• Abbott Laboratories

• Dexcom, Inc.

• Medtronic plc

• Roche Diabetes Care

• Ascensia Diabetes Care

• Becton, Dickinson and Company (BD)

• LifeScan (OneTouch)

• Ypsomed AG

• Sanofi

• Siemens Healthineers

• ARKRAY, Inc.

• Senseonics Holdings, Inc.

• Tandem Diabetes Care, Inc.

• Insulet Corporation

• Nova Biomedical

Segmentation

By Type

• BGM Devices

o Self-Monitoring Devices

o Continuous Glucose Monitoring Devices

• Insulin Delivery Devices

o Pumps

o Pens

o Syringes

o Jet Injectors

By Distribution Channel

• Hospital pharmacies

• Retail Pharmacies

• Diabetes Clinics/Centers

• Online Pharmacies

• Others

By End-use

• Hospitals

• Diagnostic Centers

• Homecare

By Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

ページTOPに戻る


Table of Contents

1. Executive Summary
1.1. Global Diabetes Monitoring Devices Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2026
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. COVID-19 Impact Analysis
2.5. Porter's Five Forces Analysis
2.6. Impact of Russia-Ukraine Conflict
2.7. PESTLE Analysis
2.8. Regulatory Analysis
2.9. Price Trend Analysis
2.9.1. Current Prices and Future Projections, 2025-2033
2.9.2. Price Impact Factors
3. Global Diabetes Monitoring Devices Market Outlook, 2020-2033
3.1. Global Diabetes Monitoring Devices Market Outlook, by Type, Value (US$ Bn), 2020-2033
3.1.1. BGM Devices
3.1.1.1. Self-Monitoring Devices
3.1.1.2. Continuous Glucose Monitoring Devices
3.1.2. Insulin Delivery Devic
3.1.2.1. Pumps
3.1.2.2. Pens
3.1.2.3. Syringes
3.1.2.4. Jet Injectors
3.2. Global Diabetes Monitoring Devices Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
3.2.1. Hospital pharmacies
3.2.2. Retail Pharmacies
3.2.3. Diabetes Clinics/Centers
3.2.4. Online Pharmacies
3.2.5. Others
3.3. Global Diabetes Monitoring Devices Market Outlook, by End-use, Value (US$ Bn), 2020-2033
3.3.1. Hospitals
3.3.2. Diagnostic Centers
3.3.3. Homecare
3.4. Global Diabetes Monitoring Devices Market Outlook, by Region, Value (US$ Bn), 2020-2033
3.4.1. North America
3.4.2. Europe
3.4.3. Asia Pacific
3.4.4. Latin America
3.4.5. Middle East & Africa
4. North America Diabetes Monitoring Devices Market Outlook, 2020-2033
4.1. North America Diabetes Monitoring Devices Market Outlook, by Type, Value (US$ Bn), 2020-2033
4.1.1. BGM Devices
4.1.1.1. Self-Monitoring Devices
4.1.1.2. Continuous Glucose Monitoring Devices
4.1.2. Insulin Delivery Devic
4.1.2.1. Pumps
4.1.2.2. Pens
4.1.2.3. Syringes
4.1.2.4. Jet Injectors
4.2. North America Diabetes Monitoring Devices Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
4.2.1. Hospital pharmacies
4.2.2. Retail Pharmacies
4.2.3. Diabetes Clinics/Centers
4.2.4. Online Pharmacies
4.2.5. Others
4.3. North America Diabetes Monitoring Devices Market Outlook, by End-use, Value (US$ Bn), 2020-2033
4.3.1. Hospitals
4.3.2. Diagnostic Centers
4.3.3. Homecare
4.4. North America Diabetes Monitoring Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
4.4.1. U.S. Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
4.4.2. U.S. Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
4.4.3. U.S. Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
4.4.4. Canada Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
4.4.5. Canada Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
4.4.6. Canada Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
4.5. BPS Analysis/Market Attractiveness Analysis
5. Europe Diabetes Monitoring Devices Market Outlook, 2020-2033
5.1. Europe Diabetes Monitoring Devices Market Outlook, by Type, Value (US$ Bn), 2020-2033
5.1.1. BGM Devices
5.1.1.1. Self-Monitoring Devices
5.1.1.2. Continuous Glucose Monitoring Devices
5.1.2. Insulin Delivery Devic
5.1.2.1. Pumps
5.1.2.2. Pens
5.1.2.3. Syringes
5.1.2.4. Jet Injectors
5.2. Europe Diabetes Monitoring Devices Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
5.2.1. Hospital pharmacies
5.2.2. Retail Pharmacies
5.2.3. Diabetes Clinics/Centers
5.2.4. Online Pharmacies
5.2.5. Others
5.3. Europe Diabetes Monitoring Devices Market Outlook, by End-use, Value (US$ Bn), 2020-2033
5.3.1. Hospitals
5.3.2. Diagnostic Centers
5.3.3. Homecare
5.4. Europe Diabetes Monitoring Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
5.4.1. Germany Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
5.4.2. Germany Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
5.4.3. Germany Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
5.4.4. Italy Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
5.4.5. Italy Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
5.4.6. Italy Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
5.4.7. France Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
5.4.8. France Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
5.4.9. France Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
5.4.10. U.K. Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
5.4.11. U.K. Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
5.4.12. U.K. Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
5.4.13. Spain Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
5.4.14. Spain Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
5.4.15. Spain Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
5.4.16. Russia Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
5.4.17. Russia Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
5.4.18. Russia Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
5.4.19. Rest of Europe Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
5.4.20. Rest of Europe Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
5.4.21. Rest of Europe Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
5.5. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Diabetes Monitoring Devices Market Outlook, 2020-2033
6.1. Asia Pacific Diabetes Monitoring Devices Market Outlook, by Type, Value (US$ Bn), 2020-2033
6.1.1. BGM Devices
6.1.1.1. Self-Monitoring Devices
6.1.1.2. Continuous Glucose Monitoring Devices
6.1.2. Insulin Delivery Devic
6.1.2.1. Pumps
6.1.2.2. Pens
6.1.2.3. Syringes
6.1.2.4. Jet Injectors
6.2. Asia Pacific Diabetes Monitoring Devices Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
6.2.1. Hospital pharmacies
6.2.2. Retail Pharmacies
6.2.3. Diabetes Clinics/Centers
6.2.4. Online Pharmacies
6.2.5. Others
6.3. Asia Pacific Diabetes Monitoring Devices Market Outlook, by End-use, Value (US$ Bn), 2020-2033
6.3.1. Hospitals
6.3.2. Diagnostic Centers
6.3.3. Homecare
6.4. Asia Pacific Diabetes Monitoring Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
6.4.1. China Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
6.4.2. China Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
6.4.3. China Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
6.4.4. Japan Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
6.4.5. Japan Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
6.4.6. Japan Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
6.4.7. South Korea Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
6.4.8. South Korea Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
6.4.9. South Korea Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
6.4.10. India Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
6.4.11. India Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
6.4.12. India Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
6.4.13. Southeast Asia Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
6.4.14. Southeast Asia Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
6.4.15. Southeast Asia Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
6.4.16. Rest of SAO Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
6.4.17. Rest of SAO Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
6.4.18. Rest of SAO Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
6.5. BPS Analysis/Market Attractiveness Analysis
7. Latin America Diabetes Monitoring Devices Market Outlook, 2020-2033
7.1. Latin America Diabetes Monitoring Devices Market Outlook, by Type, Value (US$ Bn), 2020-2033
7.1.1. BGM Devices
7.1.1.1. Self-Monitoring Devices
7.1.1.2. Continuous Glucose Monitoring Devices
7.1.2. Insulin Delivery Devic
7.1.2.1. Pumps
7.1.2.2. Pens
7.1.2.3. Syringes
7.1.2.4. Jet Injectors
7.2. Latin America Diabetes Monitoring Devices Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
7.2.1. Hospital pharmacies
7.2.2. Retail Pharmacies
7.2.3. Diabetes Clinics/Centers
7.2.4. Online Pharmacies
7.2.5. Others
7.3. Latin America Diabetes Monitoring Devices Market Outlook, by End-use, Value (US$ Bn), 2020-2033
7.3.1. Hospitals
7.3.2. Diagnostic Centers
7.3.3. Homecare
7.4. Latin America Diabetes Monitoring Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
7.4.1. Brazil Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
7.4.2. Brazil Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
7.4.3. Brazil Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
7.4.4. Mexico Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
7.4.5. Mexico Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
7.4.6. Mexico Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
7.4.7. Argentina Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
7.4.8. Argentina Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
7.4.9. Argentina Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
7.4.10. Rest of LATAM Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
7.4.11. Rest of LATAM Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
7.4.12. Rest of LATAM Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
7.5. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Diabetes Monitoring Devices Market Outlook, 2020-2033
8.1. Middle East & Africa Diabetes Monitoring Devices Market Outlook, by Type, Value (US$ Bn), 2020-2033
8.1.1. BGM Devices
8.1.1.1. Self-Monitoring Devices
8.1.1.2. Continuous Glucose Monitoring Devices
8.1.2. Insulin Delivery Devic
8.1.2.1. Pumps
8.1.2.2. Pens
8.1.2.3. Syringes
8.1.2.4. Jet Injectors
8.2. Middle East & Africa Diabetes Monitoring Devices Market Outlook, by Distribution Channel, Value (US$ Bn), 2020-2033
8.2.1. Hospital pharmacies
8.2.2. Retail Pharmacies
8.2.3. Diabetes Clinics/Centers
8.2.4. Online Pharmacies
8.2.5. Others
8.3. Middle East & Africa Diabetes Monitoring Devices Market Outlook, by End-use, Value (US$ Bn), 2020-2033
8.3.1. Hospitals
8.3.2. Diagnostic Centers
8.3.3. Homecare
8.4. Middle East & Africa Diabetes Monitoring Devices Market Outlook, by Country, Value (US$ Bn), 2020-2033
8.4.1. GCC Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
8.4.2. GCC Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
8.4.3. GCC Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
8.4.4. South Africa Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
8.4.5. South Africa Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
8.4.6. South Africa Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
8.4.7. Egypt Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
8.4.8. Egypt Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
8.4.9. Egypt Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
8.4.10. Nigeria Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
8.4.11. Nigeria Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
8.4.12. Nigeria Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
8.4.13. Rest of Middle East Diabetes Monitoring Devices Market Outlook, by Type, 2020-2033
8.4.14. Rest of Middle East Diabetes Monitoring Devices Market Outlook, by Distribution Channel, 2020-2033
8.4.15. Rest of Middle East Diabetes Monitoring Devices Market Outlook, by End-use, 2020-2033
8.5. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Company Vs Segment Heatmap
9.2. Company Market Share Analysis, 2025
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Abbott Laboratories
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Developments
9.4.2. Dexcom, Inc.
9.4.3. Medtronic plc
9.4.4. Roche Diabetes Care
9.4.5. Ascensia Diabetes Care
9.4.6. Becton, Dickinson and Company (BD)
9.4.7. LifeScan (OneTouch)
9.4.8. Ypsomed AG
9.4.9. Sanofi
9.4.10. Siemens Healthineers
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同じKEY WORD(diabetes)の最新刊レポート


よくあるご質問


Fairfield Market Research社はどのような調査会社ですか?


Fairfield Market Researchでは、最新かつ最も関連性の高い市場データと洞察に満ちた詳細なレポートを発行しています。広範囲にわたり、業界動向や市場ベースのデータを含んでおり、顧客が... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

 

2026/05/28 10:25

160.66 円

186.96 円

218.15 円

ページTOPに戻る